Status:
UNKNOWN
Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS
Lead Sponsor:
Federal University of Paraíba
Collaborating Sponsors:
City University of New York
University of Michigan
Conditions:
Coronavirus
COVID-19 Respiratory Infection
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
COVID-19 has a variety of symptoms from asymptomatic respiratory dysfunction to death. Considering the pathophysiology of SARS-CoV-2 and its relationship with the neuroimmune system, response, autonom...
Eligibility Criteria
Inclusion
- Intensive Care Unit's
- Patients of at least 18 years-old with a PCR-confirmed SARS-CoV-2 diagnosis and receiving mechanical ventilation at least 48 hours of meeting criteria for moderate to severe acute respiratory distress syndrome (ARDS), under weaning, were enrolled in this study. An ARDS diagnosis was made according to the Berlin Definition criteria.
- Intensive Care Unit's
Exclusion
- Patients were excluded if they had a condition that could prevent adequate performance of inspiratory muscle training (e.g., neuropathy or myopathy), pregnancy or active lactation, Richmond Agitation and Sedation Scale (RASS) scores between -2 and + 1, Glasgow Coma Scale (GCS) ≤ 8, consent refusal, and contraindications to brain stimulation (e.g., aneurysm clips).
Key Trial Info
Start Date :
June 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 12 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04844554
Start Date
June 20 2021
End Date
October 12 2022
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Paraíba,Department of Psychology
João Pessoa, Paraíba, Brazil, 58051-900